SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2215>>non-fucosylated antibodies<< Message 25961700 ...Seattle Geneticsnigel bates-9/22/2009
2214Finis. NEW YORK (AP) -- Bristol-Myers Squibb Co. said Thursday it completed itsnigel bates-8/28/2009
2213Maybe it isn't a done deal, although I can't see the people buying sincetnsaf-8/22/2009
2212BMS' $2.4B Grab Spotlights Platforms Attention Shoppers: Antibody Prizes NoIcebrg-7/24/2009
2211ipilumumab ?tom pope-7/23/2009
2210Bristol’s Poker Game: Doubling-Down on Research Back in December ’05 Amgen paidIcebrg17/23/2009
2209Yea, not only were they starting to look interesting but I bought this in Nov atJamesK-7/23/2009
2208Don't have near enough shares. But then as my wife always point out, if it kenhott-7/23/2009
2207Probably inevitable. But too cheap.nigel bates-7/23/2009
2206So they are taken out just when they start developing an interesting pipeline oftnsaf-7/23/2009
2205Thanks again Erik for keeping us all informed all along the way. AshleyA.J. Mullen67/22/2009
2204Good timing. Just in time for BMY to buy it for 16. Bristol-Myers Squibb to AcIRWIN JAMES FRANKEL-7/22/2009
2203>> Medx Downgrade by UBS << analysts, trying to keep busy.scaram(o)uche-7/22/2009
2202Bristol-Myers Squibb to Acquire Medarex Positions Bristol-Myers Squibb for Long-scaram(o)uche-7/22/2009
2201Medx Downgrade by UBS Risk appetite has normalized – taking a more neutral stancIcebrg-7/16/2009
2200Lifted from the Yahoo board <I>Medarex Inc. Investment Thesis We believe tom pope-7/16/2009
2199Medarex to Receive Milestone Payment from FibroGen for the Initiation of a PhaseIcebrg-7/13/2009
2198Sure thing. The SEC link has further on the Immunex connection re Vectibix or APseudo Biologist-7/9/2009
2197Sorry - silly mistake. Thanks for the correction.nigel bates-7/9/2009
2196My recollection is that denosumab was an Amgen project using ABGX technology - vPseudo Biologist-7/8/2009
2195>>It is the indication (and result) that matters<< I appreciate thanigel bates-7/8/2009
2194It is the indication (and result) that matters, not whose antibody that is used.Icebrg-7/8/2009
2193Interesting that on a day when AMGN added about $9bn to its cap. on good data frnigel bates-7/8/2009
2192SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly SubIcebrg-6/27/2009
2191Medarex has filed a Form 4 saying they sold 2.000.000 shares in Celldex @ 7,15. Icebrg-6/26/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News